• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT FREE T4 REAGENT KIT; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT FREE T4 REAGENT KIT; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Catalog Number 07K65-34
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/02/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information has been included.No additional patient details are available.
 
Event or Problem Description
The customer observed falsely elevated architect free t4 results on a patient diagnosed with hypothyroidism.The following data was provided: on (b)(6) 2023.Tsh 1.65, ft3 2.41, ft4 1.42.Sid (b)(6) , on (b)(6) 2024 , initial test, repeat test, tsh 2.8109 uiu/ml, 3.5787 uiu/ml, ft3 2.84 pg/ml, 2.33 pg/ml, ft4 >5.00 ng/dl, 1.95 ng/dl.Sid (b)(6), on (b)(6) 2024, initial test, repeat test, ft4 >5.00 ng/dl, 0.96 ng/dl.Sid (b)(6), on (b)(6) 2024, initial test, repeat test, ft4 2.05 ng/dl, 1.18 ng/dl.No impact to patient management was reported.
 
Additional Manufacturer Narrative
Data and information provided by the customer were reviewed and align with the complaint issue and no additional issues were identified.The ticket search by lot indicates that the reagent lot shows elevated complaint activity, however, in-house performance testing was completed which indicates the product is performing as expected.Device history review did not identify any non-conformances or deviations with the complaint list number.A review of ticket trending did not identify any related trend regarding commonalities for complaint lot number and issue.Retained analysis of architect free t4 reagent lot 56001ud00 was performed.Testing met acceptance criteria and the product is performing as expected.A review of the labelling addresses the customer¿s issue.Based on the investigation, no systemic issue or deficiency of the architect free t4 assay was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT FREE T4 REAGENT KIT
Common Device Name
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18917399
Report Number3005094123-2024-00126
Device Sequence Number6769913
Product Code CEC
UDI-Device Identifier00380740119805
UDI-Public00380740119805
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K173122
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/19/2023
Device Catalogue Number07K65-34
Device Lot Number56001UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/02/2024
Supplement Date Received by Manufacturer04/24/2024
Initial Report FDA Received Date03/15/2024
Supplement Report FDA Received Date04/30/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/26/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC I2K PROC MOD, 03M74-01, ISR55690; ARC I2K PROC MOD, 03M74-01, ISR55690
Patient SexUnknown
-
-